Center for Global Health Faculty

Lawrence J. Cheskin

Associate Professor

Director, Johns Hopkins Weight Management Center

Academic Degrees

Departmental Affiliation

Name:

Health, Behavior and Society

Affiliation Type:

Primary

Departmental Address

550 North Broadway, Suite 1001 Baltimore, MD 21205

Contact Information

Email:: lcheskin+jhsph.edu
Phone:: 410-502-0145
Fax:: 410-502-6719
Link:: Personal Website

Research and Professional Experience

Lawrence J. Cheskin, M.D., F.A.C.P., is Associate Professor of Health, Behavior & Society, with a joint appointment in Human Nutrition, and in Medicine at Johns Hopkins. He is also former director of the Gastroenterology Division, Johns Hopkins Bayview Medical Center. Dr. Cheskin founded the Johns Hopkins Weight Management Center in 1990. He is the principal investigator on several research grants and is a frequent contributor to research and popular articles on weight management.

Keywords

obesity treatment, weight management, gastroenterology, lifestyle and health

Honors and Awards

F.A.C.P. (Fellow of the American College of Physicians) F.A.C.G. (Fellow of the American College of Gastroenterology) National Merit Scholarship Finalist Dr. Jonas E. Salk Scholarship Certificate of Recognition, DHHS John Hartford Scholar in Geriatric Medicine Young Investigator Award, NATO-NIH Research Workshop: Obesity Treatment

Selected Publications

Cheskin LJ, Geller G, Kahan S. Commentary: Medical ethics confronts obesity. Virtual Mentor (JAMA), April 2010, in press.

DavisLM, Michaelides M, Cheskin LJ, Moran TH, Aja S, Watkins PA, Pei Z, Contoreggi C, McCullough K, Hope B, Wang GJ, Volkow ND, Thanos PK. Bromocriptine administration reduces hyperphagia and adiposity in (fa/fa) Zucker and diet-induced obese rats and is associated with dopamine (DA) D2 receptor (D2R) and DA transporter (DAT) levels. Neuroendocrinology 89(2):152-62, 2009.

Cheskin LJ, Mitola AH, Ridoré M, Kolge S, Hwang K. Clark B. A naturalistic, controlled, crossover trial of plum juice versus psyllium versus control for improving bowel function. Internet J Nutrition Wellness 7(2), 2009.

Espeland MA, Bray GA, Neiberg R, Rejeski WJ, Knowler WC, Lang W, Cheskin LJ, Williamson D, Lewis B, Wing R. Describing patterns of weight changes using principal components analysis: Results from the Action for Health in Diabetes (Look AHEAD) research group. Ann Epidemiology 19(10):701-10, 2009.

Cheskin LJ, Margolick J, Mitola AH, Kahan S, Poddar KH, et al. Effect of nutritional supplements on immune function and body weight in malnourished adults. Nutrition Metab Insights, 2010, in press.

Davis LM, Coleman C, Andersen WS, Cheskin LJ. The effect of metabolism-boosting beverages on 24-hour energy expenditure. Open Nutrition Journal 2:37-41, 2008.

Cheskin LJ, *Davis LM, *Mitola AH, *Lipsky LM, *Lycan T, *Mitchell V, *Mickle B, *Adkins E. Lack of energy compensation over 4 days when white button mushrooms are substituted for beef. Appetite 51:50-57, 2008.

Cheskin LJ. Commentary: A personal-contact weight-loss maintenance intervention reduced weight regain in overweight and obese adults. ACP Journal Club, 2008.

Cheskin LJ, Mitchell AM, *Jhaveri AD, *Mitola AH, *Davis LM, Lewis RA, Yep MA, *Lycan TW. Efficacy of meal replacements versus standard food-based diet for weight loss in type 2 diabetes: A controlled clinical trial. The Diabetes Educator 34(1):118-127, 2008.

Beydoun MA, Gary TL, Caballero BH, Lawrence RS, Cheskin LJ, Wang Y. Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome Am J Clin Nutr 87:1914 –25, 2008

Cheskin LJ, *Davis LM, *Mitola AH, *Lipsky LM, *Lycan T, *Mitchell V, *Mickle B, *Adkins E. Lack of energy compensation over 4 days when white button mushrooms are substituted for beef. Appetite, in press, 2008.

Cheskin LJ, *Prosser BJ. Obesity and the risk of colon polyps. J Clin Gastroenterol 41(3):229-30, 2007.

Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney International, Oct 10, 2007.

Pollack KM, Cheskin LJ. Obesity and workplace traumatic injury: does the science support the link? Inj Prev. 13(5):297-302, 2007.

Cheskin LJ, Burnett AL. Commentary: Therapeutics: A behavioural weight-loss programme was better than an education program for untreated, idiopathic urinary incontinence in overweight and obese women. Evidence-Based Medicine/ BMJ, 14(4):118, 2009.

Cheskin LJ, Gange S. Commentary: BMI <22.5 and >25 predicted higher overall mortality in adults. Evidence-Based Medicine/ BMJ, 14(5):152, 2009.

Neuhouser M, Rock CL, Kristal AR, Patterson RE, Neumark-Sztainer D, Cheskin LJ, Thornquist MD. Olestra is associated with slight reductions in serum carotenoids but does not markedly influence serum fat-soluble vitamin concentrations. Am J Clin Nutr. 83(3):624-31, 2006.

Sidhaye A, Cheskin LJ. Pharmacologic treatment of obesity. Adv Psychosomatic Med 27:42-52, 2006.

Davis LM, Pei Z, Trush MA, Cheskin LJ, Contoreggi C, McCullough K, Watkins PA, Moran TH. Bromocriptine reduces steatosis in obese rodent models. J Hepatology 45(3):439-44, 2006.